Rhumbline Advisers Merck & Co., Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 4,517,345 shares of MRK stock, worth $448 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

4,517,345

Previous 4,566,635 1.08%

Holding current value

$448 Million

Previous $565 Million 9.26%

% of portfolio

0.47%

Previous 0.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $5.48 Million - $6.36 Million	-49,290 Reduced 1.08%	4,517,345 $513 Million
Q2 2024 Aug 01, 2024	BUY	$123.8 - $132.96 $14.5 Million - $15.6 Million	117,473 Added 2.64%	4,566,635 $565 Million
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $12.2 Million - $14.3 Million	-108,071 Reduced 2.37%	4,449,162 $587 Million
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $2.79 Million - $3.03 Million	-27,832 Reduced 0.61%	4,557,233 $497 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $100,993 - $112,157	-981 Reduced 0.02%	4,585,065 $472 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $8.99 Million - $9.79 Million	82,735 Added 1.84%	4,586,046 $529 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $11.9 Million - $13.3 Million	115,978 Added 2.64%	4,503,311 $479 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $13.6 Million - $17.5 Million	155,683 Added 3.68%	4,387,333 $487 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $13 Million - $14.6 Million	153,744 Added 3.77%	4,231,650 $364 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $14.1 Million - $16 Million	168,944 Added 4.32%	4,077,906 $372 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $14.1 Million - $15.8 Million	192,072 Added 5.17%	3,908,962 $321 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $2.57 Million - $3.23 Million	35,622 Added 0.97%	3,716,890 $285 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $14.6 Million - $16.1 Million	-204,150 Reduced 5.25%	3,681,268 $277 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $13.2 Million - $14.6 Million	-187,129 Reduced 4.59%	3,885,418 $302 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $9.02 Million - $10.6 Million	-130,928 Reduced 3.11%	4,072,547 $314 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $16.2 Million - $18 Million	-225,612 Reduced 5.09%	4,203,475 $344 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $243,689 - $276,223	-3,330 Reduced 0.08%	4,429,087 $367 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $19.8 Million - $22.6 Million	281,529 Added 6.78%	4,432,417 $343 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $1.63 Million - $2.27 Million	25,794 Added 0.63%	4,150,888 $319 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $1.17 Million - $1.32 Million	-15,093 Reduced 0.36%	4,125,094 $375 Million
Q3 2019 Oct 23, 2019	BUY	$76.08 - $82.93 $1.28 Million - $1.39 Million	16,801 Added 0.41%	4,140,187 $349 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $1 Million - $1.17 Million	-14,348 Reduced 0.35%	4,123,386 $346 Million
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $9.69 Million - $11.1 Million	-139,288 Reduced 3.26%	4,137,734 $344 Million
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $2.09 Million - $2.43 Million	-32,071 Reduced 0.74%	4,277,022 $327 Million
Q3 2018 Nov 07, 2018	SELL	$57.69 - $67.84 $6.16 Million - $7.24 Million	-106,705 Reduced 2.42%	4,309,093 $306 Million
Q2 2018 Aug 06, 2018	SELL	$50.83 - $59.72 $2.68 Million - $3.14 Million	-52,631 Reduced 1.18%	4,415,798 $268 Million
Q1 2018 May 02, 2018	SELL	$50.96 - $59.23 $1.83 Million - $2.13 Million	-35,973 Reduced 0.8%	4,468,429 $243 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $5.67 Million - $6.77 Million	109,804 Added 2.5%	4,504,402 $253 Million
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $258 Million - $277 Million	4,394,598	4,394,598 $281 Million

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Merck & Co., Inc. Transaction History